ESMO Congress 2026

October 23–27, 2026 · Madrid · 176 items

HER2

3 people · 3 posts · 1 abstract

Evidence

NCT05113251NCT05113251

- **标题 / Title：** Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer Read the abstract →

Floor

TodayOct 23Fri

Friday · 2 items

02:17
Dana-Farber’s Breast Oncology Center@DFCI_BreastOncScore6060
Tomorrow! Don’t miss Dr. Sara Tolaney (@stolaney1) at #ESMO26 as she discusses #ADC strategies in HER2-positive #BreastCancer across the first-line metastatic and early disease set…
Same topic HER2 · 3 people #BREASTCANCERHeat 00 likes0 replies0 reposts
01:34
Kristina Jankovic, MD@JankovicKScore6060
@OncoAlert 🚨 4Sights Abstracts to be presented at #ESMO26 🇪🇸 | #evERA: Promising biomarker insights after CDK4/6i! In patients with ER+/HER2- advanced #BreastCancer in the post CD…
Same topic HER2 · 3 people #EVERA #BREASTCANCERHeat 00 likes0 replies0 reposts

Oct 19Mon

Monday · 1 items

07:04
dr_yakupergun@dr_yakupergunScore6060
In another meta-analysis of ours, to be presented at #ESMO26 , we evaluated whether adding carboplatin to taxane plus dual HER2 blockade improves pCR rates in neoadjuvant HER2+ bre…
Same topic HER2 · 3 peopleHeat 3628 likes0 replies8 reposts

Apr 23Thu

Thursday · 2 items

06:04
x.com@Score6060
During #AACR26, researchers from MSK presented on innovative therapeutic advances — including clinical trials showing promise for people ...
Same topic HER2 · 11 people KRAS #RECTALCANCER #PANCREATICCANCER #CANCERVACCINEHeat 2418 likes0 replies6 reposts
03:02
x.com@Score6060
MSK experts presented findings from their latest foundational and translational oncology research at #AACR26.
Same topic HER2 · 11 people #RECTALCANCER #PANCREATICCANCER #LUNGCANCER-ENABLINGHeat 3123 likes1 reply7 reposts

Apr 22Wed

Wednesday · 4 items

10:43
x.com@Score6060
On Sunday at #AACR26, Elizabeth K. Lee presented a phase I dose-escalation clinical trial that enrolled patients whose tumors, regardless...
Same topic HER2 · 11 peopleHeat 43 likes1 reply0 reposts
08:40
x.com@Score6060
Today, MSK physician-scientist Dr. Sarat Chandarlapaty shared his research on how #cancer develops resistance to #HER2 antibody-drug conj...
Same topic HER2 · 11 people #HER2Heat 2415 likes0 replies9 reposts
04:50
x.com@Score6060
Insightful research on anti-HER2 ADCs from Dr. Sarat Chandarlapaty at #AACR26
Same topic HER2 · 11 peopleHeat 1713 likes0 replies4 reposts
02:46
x.com@Score6060
Join MSK breast medical oncologist Dr. Sarat Chandarlapaty for a session about “Resistance to anti-HER2 ADCs” TODAY at #AACR26. @aacr
Same topic HER2 · 11 peopleHeat 75 likes0 replies2 reposts

Apr 20Mon

Monday · 3 items

19:02
LUNGevity Foundation@LUNGevityScore6060
ADC opens door to PARPi combo. Dr. Elizabeth Lee
Same topic HER2 · 11 people #HER2Heat 64 likes1 reply1 repost
15:28
Kelly Anderson@kelly_archivesScore6060
Promising momentum in HER2-positive disease. Expanding effective first-line options regardless of PD-L1 status could be a real shift for ...
Same topic HER2 · 11 peopleHeat 32 likes0 replies1 repost
06:39
Ingo Hartung@HartungIngoScore6060
Zainab Jagani of
Same topic HER2 · 11 peopleHeat 3729 likes1 reply7 reposts

Apr 19Sun

Sunday · 2 items

07:49
MBC Advocate@MBCadvocateScore6060
“Marengo Reports Initial Phase 2 Clinical Results for MBC. Encouraging Phase 2 clinical activity with confirmed complete responses observ...
Same topic HER2 · 11 peopleHeat 52 likes0 replies3 reposts
04:49
Memorial Sloan Kettering Cancer Center@MSKCancerCenterScore6060
New from #AACR26: A small clinical trial (8-person) at MSK is showing promise for people with early-stage #rectalcancer whose tumors are ...
Same topic HER2 · 11 people #RECTALCANCERHeat 3324 likes1 reply8 reposts